Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers

Por Kessler, Elizabeth R, Eckhardt, S Gail, Pitts, Todd M, Bradshaw-Pierce, Erica L, O'byrant, Cindy L, Messersmith, Wells A, Nallapreddy, Sujatha, Weekes, Colin, Spratlin, Jennifer, Lieu, Christopher H, Kane, Madeleine A, Eppers, Sarah, Freas, Elizabeth, Leong, Stephen
Publicado no Invest New Drugs (2015)

Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study

Por Cohen, Ezra E.W., Rosen, Lee S., Vokes, Everett E., Kies, Merrill S., Forastiere, Arlene A., Worden, Francis P., Kane, Madeleine A., Sherman, Eric, Kim, Sinil, Bycott, Paul, Tortorici, Michael, Shalinsky, David R., Liau, Katherine F., Cohen, Roger B.
Publicado no J Clin Oncol (2008)